This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wann, E. R.
Right arrow Articles by Leung, D. Y. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wann, E. R.
Right arrow Articles by Leung, D. Y. M.

 Previous Article  |  Next Article 

Infection and Immunity, September 1999, p. 4737-4743, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Staphylococcus aureus Isolates from Patients with Kawasaki Disease Express High Levels of Protein A

Elisabeth R. Wann,1 Amy P. Fehringer,2 Yuri V. Ezepchuk,2 Patrick M. Schlievert,3 Paul Bina,4 Raoul F. Reiser,4 Magnus M. Höök,1 and Donald Y. M. Leung2,5,*

Albert A. Alkek Institute of Biosciences and Technology, Texas A & M University Health Science Center, Houston, Texas 77030-33031; Division of Pediatric Allergy-Immunology, The National Jewish Medical and Research Center, Denver, Colorado 802062; Department of Pediatrics and Immunology, University of Colorado Health Sciences Center, Denver, Colorado 802625; Department of Microbiology, University of Minnesota, Minneapolis, Minnesota 554553; and Toxin Technology, Sarasota, Florida 342314

Received 18 February 1999/Returned for modification 13 April 1999/Accepted 30 June 1999

Kawasaki disease (KD) is an acute vasculitis of young children that can be complicated by coronary artery abnormalities. Recent findings suggest that a superantigen(s) may play an important role in stimulating the immune activation associated with the disease, although the origin of this superantigen(s) is unclear. Staphylococcus aureus, isolated from the rectum or pharynx of patients with KD, secretes toxic shock syndrome toxin 1 (TSST-1). The KD isolates express low levels of other exoproteins compared to isolates from patients with toxic shock syndrome (TSS). Thus, it was previously suggested that the KD isolates may be defective in the global regulatory locus agr (for accessory gene regulator), which positively regulates these factors (D. Y. M. Leung et al., Lancet 342:1385-1388, 1993). Here we describe another characteristic of KD isolates. When considered collectively, the KD isolates were found to express higher levels of staphylococcal protein A than the TSS isolates, another characteristic of an agr-defective phenotype. This correlated with a higher level of spa mRNA in these isolates. In contrast, the KD and TSS isolates expressed comparable levels of TSST-1, consistent with previous findings (D. Y. M. Leung et al., Lancet 342:1385-1388, 1993). Analysis of RNAIII transcript levels and nucleotide sequence analysis of the RNAIII-coding region suggested that the KD isolates are not defective in RNAIII, the effector molecule of the agr regulatory system. However, induction of RNAIII transcription in the KD isolates did not result in a dramatic decrease in the amount of spa mRNA, as has been reported for other strains (F. Vandenesch, J. Kornblum, and R. P. Novick, J. Bacteriol. 173:6313-6320, 1991).


* Corresponding author. Mailing address: National Jewish Medical and Research Center, Room K926, 1400 Jackson St., Denver, CO 80206. Phone: (303) 398-1186. Fax: (303) 270-2182. E-mail: leungd{at}njc.org.


Infection and Immunity, September 1999, p. 4737-4743, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bjerketorp, J., Nilsson, M., Ljungh, A., Flock, J.-I., Jacobsson, K., Frykberg, L. (2002). A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology 148: 2037-2044 [Abstract] [Full Text]  
  • Yarwood, J. M., McCormick, J. K., Schlievert, P. M. (2001). Identification of a Novel Two-Component Regulatory System That Acts in Global Regulation of Virulence Factors of Staphylococcus aureus. J. Bacteriol. 183: 1113-1123 [Abstract] [Full Text]  
  • Hartleib, J., Kohler, N., Dickinson, R. B., Chhatwal, G. S., Sixma, J. J., Hartford, O. M., Foster, T. J., Peters, G., Kehrel, B. E., Herrmann, M. (2000). Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 96: 2149-2156 [Abstract] [Full Text]